Evelyn Taha
FDA investigator
Appears on 2 documents from 1996 to 2009, mostly at sites in Germany. Most often cites general requirements (21 CFR 820.180).
- 2
- Documents on file
- 3.0
- Observations per 483
- 1996
- First seen
- 2009
- Most recent
What they cite most
From 3 observations- 21 CFR 820.180General requirements1
- 21 CFR 820.25(b)Personnel1
- 21 CFR 820.90(a)Nonconforming product1
Activity by year
1996: 1, 2009: 1
Where
Germany 1 · New York 1
Often inspects with
Is Evelyn Taha coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2009-07-02 | 483 Merck Kommanditgesellschaft auf AktienJul 2, 2009 · Darmstadt, Germany | Darmstadt, Germany | 3 | |
| 1996-12-20 | EIR New York Blood ServicesDec 20, 1996 · New York, New York | New York, New York | — |
About this profile
What does Evelyn Taha inspect?
Evelyn Taha appears on 2 documents on file covering 1 site, mostly in Germany.
What do they cite most often?
21 CFR 820.180 (general requirements), followed by 21 CFR 820.25(b) and 21 CFR 820.90(a).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Evelyn Taha is dated Jul 2, 2009.